These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7251906)

  • 21. Isolation and characterization of the viscous, high-molecular-mass microbial carbohydrate fraction from faeces of healthy subjects and patients with Crohn's disease and the consequences for a therapeutic approach.
    Ruseler-van Embden JG; Van Lieshout LM; Binnema DJ; Hazenberg MP
    Clin Sci (Lond); 1998 Oct; 95(4):425-33. PubMed ID: 9748418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.
    Scanlan PD; Shanahan F; O'Mahony C; Marchesi JR
    J Clin Microbiol; 2006 Nov; 44(11):3980-8. PubMed ID: 16988018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metronidazole for Crohn's disease.
    Ursing B; Kamme C
    Lancet; 1975 Apr; 1(7910):775-7. PubMed ID: 48003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a soluble bacterial carbohydrate fraction on the viscosity of intestinal contents in healthy subjects and patients with Crohn's disease.
    Hazenberg MP; Pennock-Schröder AM; Wensinck F; Van de Merwe JP
    Eur J Clin Invest; 1989 Feb; 19(1):61-4. PubMed ID: 2499463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique.
    Giaffer MH; Holdsworth CD; Duerden BI
    J Med Microbiol; 1991 Oct; 35(4):238-43. PubMed ID: 1941994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metronidazole in prevention and treatment of bacteroides infections after appendicectomy.
    Willis AT; Ferguson IR; Jones PH; Phillips KD; Tearle PV; Berry RB; Fiddian RV; Graham DF; Harland DH; Innes DB; Mee WM; Rothwell-Jackson RL; Sutch I; Kilbey C; Edwards D
    Br Med J; 1976 Feb; 1(6005):318-21. PubMed ID: 764935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction in rats of serum agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species by the faecal flora from patients with Crohn's disease and healthy subjects.
    Hazenberg MP; Van de Merwe JP; Custers-Van Lieshout LM; Pennock-Schröder AM
    J Hyg (Lond); 1984 Oct; 93(2):345-8. PubMed ID: 6501880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary oxalate recovery after oral oxalic load: an alternative method to the quantitative determination of stool fat for the diagnosis of lipid malabsorption.
    Sangaletti O; Petrillo M; Bianchi Porro G
    J Int Med Res; 1989; 17(6):526-31. PubMed ID: 2628129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease.
    Melander A; Kahlmeter G; Kamme C; Ursing B
    Eur J Clin Pharmacol; 1977 Aug; 12(1):69-72. PubMed ID: 332504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steady-state pharmacokinetics of metronidazole in Crohn's disease.
    Eradiri O; Jamali F; Thomson AB
    Biopharm Drug Dispos; 1987; 8(3):249-59. PubMed ID: 3593902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metronidazole in Crohn's disease. A double blind cross-over clinical trial.
    Blichfeldt P; Blomhoff JP; Myhre E; Gjone E
    Scand J Gastroenterol; 1978; 13(1):123-7. PubMed ID: 345410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy of Crohn's disease with metronidazole -- an uncontrolled trial --.
    Kasper H; Sommer H; Kühn HA
    Acta Hepatogastroenterol (Stuttg); 1979 Jun; 26(3):217-21. PubMed ID: 573534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double blind, placebo controlled trial of metronidazole in Crohn's disease.
    Sutherland L; Singleton J; Sessions J; Hanauer S; Krawitt E; Rankin G; Summers R; Mekhjian H; Greenberger N; Kelly M
    Gut; 1991 Sep; 32(9):1071-5. PubMed ID: 1916494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The course of Crohn disease and side effect profile with long-term treatment using metronidazole].
    Gugler R; Jensen JC; Schulte H; Vogel R
    Z Gastroenterol; 1989 Nov; 27(11):676-82. PubMed ID: 2515668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The isolation and identification of Bacteroides spp. from the normal human faecal flora.
    Duerden BI
    J Med Microbiol; 1980 Feb; 13(1):69-78. PubMed ID: 6102157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of topical metronidazole in the treatment of anorectal Crohn's disease.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(5):380-3. PubMed ID: 24459783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 14C-Glycocholate test in Crohn's disease--its value in assessment and treatment.
    Scarpello JH; Sladen GE
    Gut; 1977 Sep; 18(9):736-41. PubMed ID: 604195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of the gut microbiota of identical twins with Crohn's disease.
    Dicksved J; Halfvarson J; Rosenquist M; Järnerot G; Tysk C; Apajalahti J; Engstrand L; Jansson JK
    ISME J; 2008 Jul; 2(7):716-27. PubMed ID: 18401439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Crohn's disease with metronidazole in childhood and adolescence. Evaluation of a six months trial.
    Hildebrand H; Berg NO; Hoevels J; Ursing B
    Gastroenterol Clin Biol; 1980 Jan; 4(1):19-25. PubMed ID: 6989700
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of Crohn's disease with metronidazole (author's transl)].
    Schneider MU; Strobel S; Riemann JF; Demling L
    Dtsch Med Wochenschr; 1981 Sep; 106(36):1126-9. PubMed ID: 6114847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.